<DOC>
	<DOCNO>NCT00943501</DOCNO>
	<brief_summary>This trial conduct Europe United States America ( USA ) . The aim clinical trial investigate safety , tolerability , pharmacokinetics ( determination concentration administer medication blood time ) pharmacodynamics ( determination effect time duration action ) multiple dos liraglutide pediatric population ( child ) .</brief_summary>
	<brief_title>Safety Liraglutide Pediatric Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>BMI great 85th percentile age gender Currently treat diet exercise metformin alone HbA1c ( glycosylated haemoglobin ) 6.5 11.0 % Any clinically significant disease type 2 diabetes , judge trial physician Previous treatment antidiabetic drug metformin ( except prior short term treatment , discretion trial physician )</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>